[go: up one dir, main page]

WO1999058699A3 - Facteurs de coagulation du sang humain derives de plantes transgeniques - Google Patents

Facteurs de coagulation du sang humain derives de plantes transgeniques Download PDF

Info

Publication number
WO1999058699A3
WO1999058699A3 PCT/US1999/010732 US9910732W WO9958699A3 WO 1999058699 A3 WO1999058699 A3 WO 1999058699A3 US 9910732 W US9910732 W US 9910732W WO 9958699 A3 WO9958699 A3 WO 9958699A3
Authority
WO
WIPO (PCT)
Prior art keywords
coagulation factors
plant
transgenic plant
human blood
derived human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/010732
Other languages
English (en)
Other versions
WO1999058699A2 (fr
Inventor
Brian S Hooker
Jianwei Gao
Daniel B Anderson
Ziyu Dai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Memorial Institute Inc
Original Assignee
Battelle Memorial Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Memorial Institute Inc filed Critical Battelle Memorial Institute Inc
Priority to EP99921969A priority Critical patent/EP1076698A2/fr
Priority to CA002328493A priority patent/CA2328493A1/fr
Priority to JP2000548490A priority patent/JP2002514433A/ja
Publication of WO1999058699A2 publication Critical patent/WO1999058699A2/fr
Publication of WO1999058699A3 publication Critical patent/WO1999058699A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

L'invention concerne une composition pour plantes transgéniques et pour des facteurs de coagulation humains dérivés de ces plantes transgéniques et capables d'éliciter une réaction d'activation dans le processus de coagulation et par conséquent utiles pour le traitement de patients humains chez lesquels une déficience des protéines du facteur de coagulation a été diagnostiquée. Ces protéines peuvent être produites par des procédés permettant une production non virale, comprenant l'utilisation de plantes entières et de cultures de cellules de plantes. L'invention concerne également des vecteurs d'expression assurant une transformation correcte du tissu végétal pour la production de ces facteurs, ainsi que des cellules de plantes transformées et des procédés permettant de produire des facteurs de coagulation humains par des techniques de biologie moléculaire végétale.
PCT/US1999/010732 1998-05-14 1999-05-14 Facteurs de coagulation du sang humain derives de plantes transgeniques Ceased WO1999058699A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP99921969A EP1076698A2 (fr) 1998-05-14 1999-05-14 Facteurs de coagulation du sang humain derives de plantes transgeniques
CA002328493A CA2328493A1 (fr) 1998-05-14 1999-05-14 Facteurs de coagulation du sang humain derives de plantes transgeniques
JP2000548490A JP2002514433A (ja) 1998-05-14 1999-05-14 トランスジェニック植物由来ヒト凝血因子

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8000398A 1998-05-14 1998-05-14
US30684799A 1999-05-06 1999-05-06
US09/306,847 1999-05-06
US09/080,003 1999-05-06

Publications (2)

Publication Number Publication Date
WO1999058699A2 WO1999058699A2 (fr) 1999-11-18
WO1999058699A3 true WO1999058699A3 (fr) 2000-04-06

Family

ID=26762686

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/010732 Ceased WO1999058699A2 (fr) 1998-05-14 1999-05-14 Facteurs de coagulation du sang humain derives de plantes transgeniques

Country Status (4)

Country Link
EP (1) EP1076698A2 (fr)
JP (1) JP2002514433A (fr)
CA (1) CA2328493A1 (fr)
WO (1) WO1999058699A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2272648C2 (ru) * 2000-05-10 2006-03-27 Ново Нордиск Хелт Кэр Аг Фармацевтическая композиция, содержащая фактор viia и фактор xiii
ATE311198T1 (de) * 2000-05-10 2005-12-15 Novo Nordisk Healthcare Ag Pharmazeutische zusammensetzung enthaltend einen faktor viia und einen tfpi-inhibitor
ES2640613T3 (es) * 2000-07-21 2017-11-03 Revance Therapeutics, Inc. Sistemas de transporte de agentes biológicos de múltiples componentes
KR20040032147A (ko) 2001-07-06 2004-04-14 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 유전자 재조합 기술에 의한 인간 트롬빈 제조 방법
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
KR20050043734A (ko) * 2001-11-09 2005-05-11 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ⅶ 폴리펩티드와 인자 ⅴ 폴리펩티드를 포함하는약제적 조성물
WO2005123928A1 (fr) * 2004-06-08 2005-12-29 Battelle Memorial Institute Production du facteur viii de coagulation humain à partir de cellules végétales et de plantes entières
CN101014711A (zh) 2004-06-25 2007-08-08 阿尔特生物科学公司 植物中组织因数的制造
TW202417621A (zh) * 2022-10-18 2024-05-01 博唯弘展生技股份有限公司 在植物系統中生產重組人類凝血酶蛋白質及其應用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268772A2 (fr) * 1986-09-19 1988-06-01 ZymoGenetics, Inc. Expression du facteur XIII biologiquement actif
WO1991002066A1 (fr) * 1989-07-26 1991-02-21 Mogen International N.V. Production de proteines heterologues dans les vegetaux et cellules vegetales
WO1993013208A1 (fr) * 1991-12-31 1993-07-08 Zymogenetics, Inc. Procedes de production de thrombine
WO1994017415A1 (fr) * 1993-01-29 1994-08-04 Dahlbaeck Bjoern Nouvelle activite de cofacteur anticoagulant
US5723755A (en) * 1995-05-16 1998-03-03 Francis E. Lefaivre Large scale production of human or animal proteins using plant bioreactors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268772A2 (fr) * 1986-09-19 1988-06-01 ZymoGenetics, Inc. Expression du facteur XIII biologiquement actif
WO1991002066A1 (fr) * 1989-07-26 1991-02-21 Mogen International N.V. Production de proteines heterologues dans les vegetaux et cellules vegetales
WO1993013208A1 (fr) * 1991-12-31 1993-07-08 Zymogenetics, Inc. Procedes de production de thrombine
WO1994017415A1 (fr) * 1993-01-29 1994-08-04 Dahlbaeck Bjoern Nouvelle activite de cofacteur anticoagulant
US5723755A (en) * 1995-05-16 1998-03-03 Francis E. Lefaivre Large scale production of human or animal proteins using plant bioreactors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CRAMER C L ET AL: "Bioproduction of human enzymes in transgenic tobacco.", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, (1996 MAY 25) 792 62-71. REF 50, XP000856387 *
DAI Z Y (REPRINT) ET AL: "Expression of human coagulation factor VIII gene in tobacco.", PLANT PHYSIOLOGY, (JUL 1997) VOL. 114, NO. 3, SUPP. [S], PP. 1584-1584. PUBLISHER: AMER SOC PLANT PHYSIOLOGISTS, 15501 MONONA DRIVE, ROCKVILLE, M 20855. ISSN: 0032-0889., BATTELLE MEM INST, PACIFIC NW LABS, BIOPROC GRP, RICHLAND, WA 99352, XP002123654 *
KANE W H ET AL: "Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting region.", BIOCHEMISTRY, (1990 JUL 24) 29 (29) 6762-8., XP002123653 *

Also Published As

Publication number Publication date
WO1999058699A2 (fr) 1999-11-18
CA2328493A1 (fr) 1999-11-18
EP1076698A2 (fr) 2001-02-21
JP2002514433A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
BR9912875A (pt) Método para a recuperação de proteìnas a partir do fluido intersticial de tecidos vegetais
AR004938A1 (es) Proteina derivada de alfa-hordotionina de alto contenido en metionina, secuencias de nucleotidos, arn y adn, cassete de expresion, vector detransformacion bacteriana, celulas bacterianas y vegetales transformadas, celula o cultivo de tejidos de maiz y metodo para potenciar el contenido de
ATE526818T1 (de) Gentechnisch hergestellte wasserlinse
EP2169069A3 (fr) Protéines de phosphatase liées au stress et procédés d'utilisation dans des plantes
ATE517185T1 (de) Methoden zur herstellung von pflanzen mit erhöhtem ölsäuregehalt
IE881323L (en) Plant tissue transformation
EP2465921A3 (fr) Cellules souches de cýur obtenues par biopsie
SG2013021217A (en) Production of high mannose proteins in plant culture
WO2001045492A3 (fr) Proteines de proteine kinase liees au stress et procedes d'utilisation dans les plantes
WO2003007873A3 (fr) Matrices a base de proteines de plasma et procedes de fabrication
WO2004022696A3 (fr) Supports de cellules de fibrine et procedes pour les utiliser
WO1999058699A3 (fr) Facteurs de coagulation du sang humain derives de plantes transgeniques
SE8800157D0 (sv) Transformation and foreign gene expression in brassica species
WO2003053216A3 (fr) Structures poreuses biodegradables utiles pour la croissance de tissus vivants et procedes de fabrication associes
DE60014635D1 (de) Verfahren zur expression und isolierung von rekombinanten proteinen und rekombinanten proteinprodukten von pflanzen, pflanzlichen geweben oder kultivierten pflanzenzellen
WO2000056905A3 (fr) Procede pour accelerer et/ou ameliorer la croissance et/ou le rendement de vegetaux ou pour modifier leur architecture
EP0249432A3 (fr) Transformation et expression de gènes étrangers avec des espèces végétales
WO2004038004A3 (fr) Systeme vasculaire a base de fibrine produit par genie tissulaire
WO2000078927A3 (fr) Preparation spheroide
EP1734126A3 (fr) Régénération
CA2275974A1 (fr) Procedes permettant de produire des plantes transgeniques femelles steriles
JP2004500809A5 (fr)
CN104911142B (zh) 一种鹿真皮毛乳头细胞的体外分离培养方法及应用
WO1999013083A3 (fr) Methode et dispositif de modulation de proteines de cycle cellulaire vegetal et leur utilisation dans la regulation de la croissance de cellules vegetales
ES2132027A1 (es) Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref document number: 2328493

Country of ref document: CA

Ref country code: CA

Ref document number: 2328493

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 548490

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999921969

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999921969

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999921969

Country of ref document: EP